Literature DB >> 23709658

Impaired left ventricular mechanics in pulmonary arterial hypertension: identification of a cohort at high risk.

Evan L Hardegree1, Arun Sachdev, Eric R Fenstad, Hector R Villarraga, Robert P Frantz, Michael D McGoon, Jae K Oh, Naser M Ammash, Heidi M Connolly, Benjamin W Eidem, Patricia A Pellikka, Garvan C Kane.   

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling and right heart failure. The right (RV) and left ventricles (LV) do not function in isolation, sharing a common pericardial sac and interventricular septum. We sought to define the clinical and prognostic significance of ventricular interdependence in PAH and its association with LV filling patterns through speckle-tracking strain echocardiography. METHODS AND
RESULTS: Echocardiography was performed in 71 adults with a new diagnosis of PAH. To analyze LV and RV function separately, we measured peak systolic longitudinal and circumferential strain of the LV and RV. Survival was assessed >2 years. Patients had dilated right-sided chambers (right atrial volume index, 44 ± 19 mL/m(2); RV end-diastolic area, 34 ± 9 cm(2)), and reduced RV function (RV fractional area change, 28 ± 12%). Speckle-tracking echocardiography revealed significant reductions in RV free wall peak systolic strain (-15 ± 3%). Despite normal LV size and normal conventional measures of LV systolic function (end-diastolic dimension, 42 ± 6 mm; ejection fraction, 65 ± 8%; cardiac index, 2.6 ± 0.8 L/min per m(2)), patients had reduced LV free wall systolic strain (-15 ± 3%). Decreased LV free wall systolic strain was associated with a delayed relaxation mitral inflow Doppler pattern, P=0.0002. During 2-year follow-up, 19 patients (27%) died. LV strain was associated with increased mortality (unadjusted hazard ratio, 2.40 per 5% decrease in LV free wall strain, 1.22-4.68), which remained significant when adjusted for age, sex, World Health Organization functional class, and PAH pathogenesis (hazard ratio, 3.11, 1.38-7.20).
CONCLUSIONS: The pressure loading in PAH results in geometric alterations and functional decline of the RV, with marked reduction in RV systolic strain. Despite preservation of LV ejection fraction, LV systolic strain was also reduced and associated with early mortality, highlighting the significance of ventricular interdependence in PAH.

Entities:  

Keywords:  diastolic function; echocardiography; heart ventricles; hypertension, pulmonary; risk prediction; strain rate

Mesh:

Year:  2013        PMID: 23709658     DOI: 10.1161/CIRCHEARTFAILURE.112.000098

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  37 in total

1.  Impact of lowering pulmonary vascular resistance on right and left ventricular deformation in pulmonary arterial hypertension.

Authors:  Gabriela Querejeta Roca; Patricia Campbell; Brian Claggett; Ali Vazir; Debbie Quinn; Scott D Solomon; Amil M Shah
Journal:  Eur J Heart Fail       Date:  2014-11-04       Impact factor: 15.534

2.  Apparent Aortic Stiffness in Children With Pulmonary Arterial Hypertension: Existence of Vascular Interdependency?

Authors:  Michal Schäfer; D Dunbar Ivy; Steven H Abman; Alex J Barker; Lorna P Browne; Brian Fonseca; Vitaly Kheyfets; Kendall S Hunter; Uyen Truong
Journal:  Circ Cardiovasc Imaging       Date:  2017-02       Impact factor: 7.792

Review 3.  Strain, strain rate, torsion, and twist: echocardiographic evaluation.

Authors:  Anders Opdahl; Thomas Helle-Valle; Helge Skulstad; Otto A Smiseth
Journal:  Curr Cardiol Rep       Date:  2015-03       Impact factor: 2.931

4.  Association of native T1 times with biventricular function and hemodynamics in precapillary pulmonary hypertension.

Authors:  Yin Yin Chen; Hong Yun; Hang Jin; De Hong Kong; Yu Liang Long; Cai Xia Fu; Shan Yang; Meng Su Zeng
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-17       Impact factor: 2.357

5.  Comparison of systemic right ventricular function in transposition of the great arteries after atrial switch and congenitally corrected transposition of the great arteries.

Authors:  Michael Morcos; Philip J Kilner; David J Sahn; Harold I Litt; Emanuela R Valsangiacomo-Buechel; Florence H Sheehan
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-01       Impact factor: 2.357

6.  Impact of Pulmonary Hemodynamics and Ventricular Interdependence on Left Ventricular Diastolic Function in Children With Pulmonary Hypertension.

Authors:  Dale A Burkett; Cameron Slorach; Sonali S Patel; Andrew N Redington; D Dunbar Ivy; Luc Mertens; Adel K Younoszai; Mark K Friedberg
Journal:  Circ Cardiovasc Imaging       Date:  2016-09       Impact factor: 7.792

7.  Right ventricular to left ventricular diameter ratio at end-systole in evaluating outcomes in children with pulmonary hypertension.

Authors:  Pei-Ni Jone; Julie Hinzman; Brandie D Wagner; David Dunbar Ivy; Adel Younoszai
Journal:  J Am Soc Echocardiogr       Date:  2013-12-08       Impact factor: 5.251

8.  Cardiac Magnetic Resonance Evaluation of Left Ventricular Myocardial Strain in Pulmonary Hypertension.

Authors:  Kimberly Kallianos; Gabriel C Brooks; Kanae Mukai; Florent Seguro de Carvalho; Jing Liu; David M Naeger; Teresa De Marco; Karen G Ordovas
Journal:  Acad Radiol       Date:  2017-08-31       Impact factor: 3.173

9.  Arterial-ventricular and interventricular interaction in isolated post-capillary and combined pulmonary hypertension in severe mitral stenosis.

Authors:  Ashwin Venkateshvaran; Srikanth Sola; Satish Chandra Govind; Pravat Kumar Dash; Sagar Vyavahare; Lars H Lund; Bé la Merkely; Anikó Ilona Nagy; Aristomenis Manouras
Journal:  Eur J Appl Physiol       Date:  2016-05-19       Impact factor: 3.078

10.  Left Ventricular Myocardial Function in Children With Pulmonary Hypertension: Relation to Right Ventricular Performance and Hemodynamics.

Authors:  Dale A Burkett; Cameron Slorach; Sonali S Patel; Andrew N Redington; D Dunbar Ivy; Luc Mertens; Adel K Younoszai; Mark K Friedberg
Journal:  Circ Cardiovasc Imaging       Date:  2015-08       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.